Physician profile
Nathaniel Hill
NPI 1609066026
$13,755.47
in general payments reported to CMS, 2019-2025
12 companies · $4,503 in 2025
The $4,503 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.76 · 2020: $8,386 · 2021: $194 · 2022: $401 · 2023: $148 · 2024: $105 · 2025: $4,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $755.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,442.33 | 2020-2025 | Da Vinci Surgical System |
| Davol INC. | $67.08 | 2024 | Phasix Mesh |
| Medtronic, INC. | $49.32 | 2025 | Transorb, Gia |
| Conmed Corporation | $37.79 | 2025 | Airseal, Conmed Specimen Retrieval |
| Acera Surgical, INC. | $32.35 | 2025 | Restrata Wound Matrix |
| Ethicon US, LLC | $21.42 | 2021 | |
| Tela Bio, INC. | $19.14 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $18.76 | 2019 | |
| Becton, Dickinson and Company | $18.67 | 2024 | Phasix Mesh |
| Organogenesis INC. | $17.68 | 2021 | |
| Reprise Biomedical, INC. | $15.55 | 2021 | |
| Innocoll Pharmaceuticals Limited | $15.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.